about
Exosomes as the source of biomarkers of metabolic diseasesRole of circulating factors in cardiac aging.Impact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients.Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic Health.High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects.Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.Association between plasma gamma-glutamyltransferase fractions and metabolic syndrome among hypertensive patients.Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology.Specific plasma amino acid disturbances associated with metabolic syndrome.Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells.Relationship between family history of type 2 diabetes and serum FGF21.Elevated Serum Cyclophilin B Levels Are Associated with the Prevalence and Severity of Metabolic Syndrome.Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases.Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA.miR-758-3p: a blood-based biomarker that's influence on the expression of CERP/ABCA1 may contribute to the progression of obesity to metabolic syndrome.
P2860
Q28069419-7BCE51D0-185A-4554-A629-D753C3DF417FQ30234641-F5802FD7-A652-4B13-BBA2-C9AC96976159Q33596891-3B37CDC7-BC2A-4FE4-B398-26D117007613Q36216763-2F4C77E1-C59F-42E1-B675-12FE703E3946Q38660162-0AAED80C-FE31-4ECC-BEA3-588C9EB74FC6Q39454229-2AC85CA6-A04F-4A3D-8055-DA8704884EE2Q41696932-FC107497-1A21-4856-B75D-A0533F5F26B3Q46268171-22A15E28-5E08-469A-9158-A9020E080223Q47138133-182F8250-C02B-4CDB-8020-6C22FACF4BCFQ47281255-05764874-51BE-4477-81F6-4300B0F4B815Q48021372-EEF4F9DA-5067-4243-AE7D-21A34EEF5213Q49180208-C67130E0-E523-4023-9EFB-57DE8B5EFE7CQ49942942-2D952FCF-38EF-475A-BAC9-C26E5E8616F0Q52665673-661CB963-C176-41AD-85F4-B0E2D9FEEE97Q55002965-E4712B4F-D73A-4991-8AB6-223DAF4CC654
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Blood-Based Biomarkers for Metabolic Syndrome.
@en
type
label
Blood-Based Biomarkers for Metabolic Syndrome.
@en
prefLabel
Blood-Based Biomarkers for Metabolic Syndrome.
@en
P2093
P1476
Blood-Based Biomarkers for Metabolic Syndrome.
@en
P2093
Kjeld Hermansen
Mette Bohl
Sadhbh O'Neill
Soren Gregersen
P304
P356
10.1016/J.TEM.2016.03.012
P577
2016-04-14T00:00:00Z